Benfotiamine protects MPTP-induced Parkinson’s disease mouse model via activating Nrf2 signaling pathway
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0307012 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Kai Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Shushan District, Hefei, Anhui Province, People's Republic of Chi…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Signal Transduction, Neuroprotective Agents, Disease Models, Animal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Major Projects in Anhui Province, Natural Science Foundation of Anhui Province.
Abstract (Originalsprache)
The pursuit of drugs and methods to safeguard dopaminergic neurons holds paramount importance in Parkinson’s disease (PD) research. Benfotiamine (BFT) has demonstrated neuroprotective properties, yet its precise mechanisms in PD remain elusive. This study investigated BFT’s potential protective effects against dopamine neuron damage in a PD animal model and the underlying mechanisms. The PD mouse model was induced by 5 consecutive MPTP injections, followed by BFT intervention for 28 days. Motor deficits were assessed via pole test, hang test, gait analysis, and open field test, while dopaminergic neuron damage was evaluated through Immunofluorescence, Nissl staining, and Western blot analysis of Tyrosine Hydroxylase (TH) in the substantia nigra and striatum. High Performance Liquid Chromatography quantified dopamine (DA) levels and its metabolites. Genetic pathways were explored using RNA-seq and bioinformatics analysis on substantia nigra tissues, confirmed by qPCR. Activation of the Nrf2 pathway was examined through nuclear translocation and expression of downstream antioxidant enzymes HO-1, GCLM, and NQO1 at mRNA and protein levels. Additionally, measurements of MDA content, GSH activity, and SOD activity were taken in the substantia nigra and striatum. BFT administration improved motor function and protected against dopaminergic neuron degeneration in MPTP mice, with partial recovery in TH expression and DA levels. RNA-seq analysis revealed distinct effects of BFT and the NLRP3 inhibitor MCC950 on Parkinson-related pathways and genes. Control of Nrf2 proved crucial for BFT, as it facilitated Nrf2 movement to the nucleus, upregulating antioxidant genes and enzymes while mitigating oxidative damage. This study elucidates BFT’s neuroprotective effects in a PD mouse model via Nrf2-mediated antioxidant mechanisms and gene expression modulation, underscoring its potential as a therapeutic agent for PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Shushan District, Hefei, Anhui Province, People's Republic of China.
- Department of Neurology, The Third Affiliated Hospital of Anhui Medical University, Luyang District, Hefei, Anhui Province, People's Republic of China.
- Division of Life Sciences and Medicine, Department of Neurology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Luyang District, Hefei, Anhui Province, People's Republic of China.
- Department of Critical Care Medicine, The Affiliated Fuyang People's Hospital of Anhui Medical University, Chengnanxin District, Fuyang, Anhui Province, People's Republic of China.
ORCID-Profile: Yu Wang
Förderung
- National Natural Science Foundation of China
- Science and Technology Major Projects in Anhui Province
- Natural Science Foundation of Anhui Province
- fellowship of China Postdoctoral Science Foundation
Zitieren
APA
Wang, K., Han, C., Yang, J., Xu, W., Wang, L., Li, H., & Wang, Y. (2024). Benfotiamine protects MPTP-induced Parkinson’s disease mouse model via activating Nrf2 signaling pathway. PLOS ONE. https://doi.org/10.1371/journal.pone.0307012
Vancouver
Wang K, Han C, Yang J, Xu W, Wang L, Li H, et al. Benfotiamine protects MPTP-induced Parkinson’s disease mouse model via activating Nrf2 signaling pathway. PLOS ONE. 2024. doi:10.1371/journal.pone.0307012
BibTeX
@article{Wang2024,
author = {Wang, Kai and Han, Chao and Yang, Jinwei and Xu, Wenhao and Wang, Lei and Li, Huaiyu and Wang, Yu},
title = {Benfotiamine protects MPTP-induced Parkinson’s disease mouse model via activating Nrf2 signaling pathway},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0307012}
}
EUVIMED